NCT04553705 - Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

September 20, 2020

Primary Completion Date

November 4, 2020

Study Completion Date

December 4, 2021

Conditions

Covid19Immunodeficiency

Interventions

DRUG

Omega 3/Nigella Sativa Oil

"Omega-3 supplementation 1000mg contains (300-400mg EPA \& 200-300mg DHA)~Nigella sativa supplementation (1g black seed oil contain 3% thymoquinone"

DRUG

Omega 3/Nigella Sativa Oil/Indian Costus

"Omega-3 supplementation 1000mg contains (300-400mg EPA \& 200-300mg DHA)~Nigella sativa supplementation (1g black seed oil contain 3% thymoquinone~Indian Costus supplements"

DRUG

Omega 3/Nigella Sativa Oil/Quinine pills

"Omega-3 supplementation 1000mg contains (300-400mg EPA \& 200-300mg DHA)~Nigella sativa supplementation (1g black seed oil contain 3% thymoquinone~Quinine supplementation (1g Quinine)"

DRUG

Omega 3/Nigella Sativa Oil/Anise seed capsule

"Omega-3 supplementation 1000mg contains (300-400mg EPA \& 200-300mg DHA)~Nigella sativa supplementation (1g black seed oil contain 3% thymoquinone~Anise seed supplementation (450mg anise seed)"

DRUG

Omega 3/Nigella Sativa Oil/Deglycyrrhizinated Licorice

"Omega-3 supplementation 1000mg contains (300-400mg EPA \& 200-300mg DHA)~Nigella sativa supplementation (1g black seed oil contain 3% thymoquinone~Deglycyrrhizinated Licorice 800 mg"

DRUG

Active Comparator

Standard protocol care of COVID-19 infection

Trial Locations (1)

Unknown

Maternity and Children hospital, Mecca

All Listed Sponsors

collaborator

Maternity and Children Hospital, Makkah

OTHER

collaborator

University of Arizona

OTHER

lead

Beni-Suef University

OTHER